Susquehanna Portfolio Strategies’s Avidity Biosciences RNAM Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-131,104	Closed	-$9.46M	–	1082
2025 Q4	$9.46M	Hold	131,104	–	–	0.15%	201
2025 Q3	$5.71M	Buy	131,104 +66,861	+104%	+$2.7M	0.09%	293
2025 Q2	$1.82M	Buy	+64,243	New	+$1.91M	0.04%	391

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Susquehanna Portfolio Strategies's RNAM Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 131,104 shares — an estimated $9.46M sold.

Susquehanna Portfolio Strategies first reported a position in RNAM in Q2 2025 and held it in 3 quarters. The position peaked at $9.46M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Susquehanna Portfolio Strategies reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Susquehanna Portfolio Strategies sold 131,104 Avidity Biosciences shares in Q1 2026, an estimated $9.46M.
Susquehanna Portfolio Strategies first reported a position in Avidity Biosciences in Q2 2025 and held it in 3 quarters.
Susquehanna Portfolio Strategies's Avidity Biosciences position peaked at $9.46M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.